Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDivestmentsFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Cash from Financing Activities (2019 - 2025)

Cresco Labs filings provide 7 years of Cash from Financing Activities readings, the most recent being -$1.8 million for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities rose 95.73% to -$1.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$117.4 million, a 207.07% decrease, with the full-year FY2025 number at -$82.1 million, down 14.84% from a year prior.
  • Cash from Financing Activities hit -$1.8 million in Q4 2025 for Cresco Labs, up from -$71.1 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $155.9 million in Q3 2021 to a low of -$71.1 million in Q3 2025.
  • Median Cash from Financing Activities over the past 5 years was -$2.4 million (2021), compared with a mean of $9.4 million.
  • Biggest five-year swings in Cash from Financing Activities: surged 1057.69% in 2021 and later crashed 2785.39% in 2025.
  • Cresco Labs' Cash from Financing Activities stood at -$2.4 million in 2021, then increased by 14.48% to -$2.0 million in 2022, then crashed by 86.21% to -$3.8 million in 2023, then tumbled by 1011.42% to -$42.0 million in 2024, then surged by 95.73% to -$1.8 million in 2025.
  • The last three reported values for Cash from Financing Activities were -$1.8 million (Q4 2025), -$71.1 million (Q3 2025), and -$42.0 million (Q4 2024) per Business Quant data.